The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1675
ISSUE 1675
May 1, 2023
Issue 1675
- Vibrant – An Oral Vibrating Capsule for Chronic Idiopathic Constipation
- Altuviiio – A Longer-Acting Factor VIII Product for Hemophilia A
- Lenacapavir (Sunlenca) for Multidrug-Resistant HIV
- Cyclosporine Ophthalmic Emulsion (Verkazia) for Vernal Keratoconjunctivitis
- In Brief: Over-the-Counter Narcan Nasal Spray
- Vaccination Recommendations for Bivalent mRNA COVID-19 Vaccines (online only)
- Dosing Recommendations for Novavax and Johnson & Johnson COVID-19 Vaccines (online only)
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Vibrant – An Oral Vibrating Capsule for Chronic Idiopathic Constipation
May 1, 2023 (Issue: 1675)
The Vibrant orally administered vibrating capsule
(Vibrant Gastro), an FDA-cleared medical device, is
now available by prescription for treatment of adults
with chronic idiopathic constipation (CIC) who have
not experienced relief of their bowel...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.